Interview with Merab Kokaia concerning CombiGene’s long-term study
November 29, 2017
The long-term study, part of CombiGene's epilepsy project, is a decisive preclinical proof-of-concept-study, the results of
The long-term study, part of CombiGene's epilepsy project, is a decisive preclinical proof-of-concept-study, the results of